2 Due to PD predominantly being a disease associated with depletion of dopamine, current therapies focus on repleting, mimicking, or preventing the degradation of this neurotransmitter
[11] Peptide-based treatments are not a standalone solution and are most effective when used alongside dietary modification, increased physical activity, and behavioural support
ROSE-010, a GLP-1 analog, was tested in a randomized, placebo-controlled clinical trial for treating acute pain in IBS patients [56]
To further explore whether the effect of GLP-1R-based agonists on MASLD depends on their weight-loss effect, we performed UVMR and MVMR to identify the risk factor whose effect on MASLD is independent of BMI
With the dual effect of "diabetes" and "weight loss", the development of GLP-1 long-acting receptor agonists has become a research hotspot at home and abroad
Please verify your specific plans coverage with your insurer or through Klaritys benefits check before booking